Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Morphic Holding Inc (MORF)

Morphic Holding Inc (MORF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,706,703
  • Shares Outstanding, K 50,094
  • Annual Sales, $ 520 K
  • Annual Income, $ -152,100 K
  • 60-Month Beta 1.49
  • Price/Sales 3,270.05
  • Price/Cash Flow N/A
  • Price/Book 2.57
Trade MORF with:

Options Overview Details

View History
  • Implied Volatility 81.57% ( -1.12%)
  • Historical Volatility 80.07%
  • IV Percentile 57%
  • IV Rank 47.99%
  • IV High 111.44% on 02/05/24
  • IV Low 54.00% on 09/08/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 8
  • Put/Call OI Ratio 22.81
  • Today's Open Interest 2,310
  • Open Int (30-Day) 2,232

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.95
  • Number of Estimates 4
  • High Estimate -0.90
  • Low Estimate -1.05
  • Prior Year -0.92
  • Growth Rate Est. (year over year) -3.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.25 +34.93%
on 06/18/24
34.70 -1.82%
on 06/28/24
+3.30 (+10.71%)
since 05/28/24
3-Month
25.25 +34.93%
on 06/18/24
35.56 -4.19%
on 04/01/24
-1.13 (-3.21%)
since 03/28/24
52-Week
19.34 +76.12%
on 11/01/23
62.08 -45.12%
on 08/02/23
-22.86 (-40.15%)
since 06/28/23

Most Recent Stories

More News
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Morphic Holding, Inc. (MORF)

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Morphic Holding, Inc. ("Morphic" or the "Company") (NASDAQ: MORF). Such...

MORF : 34.07 (+0.18%)
MORF INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into Morphic Holding, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

/PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Morphic...

MORF : 34.07 (+0.18%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Morphic Holding, Inc. (MORF)

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Morphic Holding, Inc. ("Morphic" or the "Company") (NASDAQ: MORF). Such...

MORF : 34.07 (+0.18%)
MillerKnoll, Peloton rise; Progress Software, NextEra Energy fall, Wednesday, 9/27/2023

Stocks that traded heavily or had substantial price changes on Wednesday: MillerKnoll, Peloton rise; Progress Software, NextEra Energy fall

AIR : 72.70 (+1.03%)
PTON : 3.38 (-1.74%)
PRGS : 54.26 (+0.04%)
NEE : 70.81 (-3.95%)
AN : 159.38 (+1.64%)
MORF : 34.07 (+0.18%)
Stocks Recover Early Losses on Soft Landing Optimism for the U.S. Economy

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up...

$SPX : 5,460.48 (-0.41%)
SPY : 544.22 (-0.39%)
$DOWI : 39,118.86 (-0.12%)
DIA : 391.13 (-0.11%)
$IUXX : 19,682.87 (-0.54%)
QQQ : 479.11 (-0.52%)
SEE : 34.79 (-1.11%)
DOW : 53.05 (+0.17%)
NVDA : 123.54 (-0.36%)
AMZN : 193.25 (-2.32%)
STLD : 129.50 (+3.56%)
CLF : 15.39 (+2.60%)
Stocks Mixed as Global Bond Yields Climb

The S&P 500 Index ($SPX ) (SPY ) today is up +0.23%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.02%, and the Nasdaq ($IUXX ) (QQQ ) is up +0.26%. Stocks are mixed, with the S&P 500 earlier...

$SPX : 5,460.48 (-0.41%)
SPY : 544.22 (-0.39%)
$DOWI : 39,118.86 (-0.12%)
DIA : 391.13 (-0.11%)
$IUXX : 19,682.87 (-0.54%)
QQQ : 479.11 (-0.52%)
UAL : 48.66 (+0.95%)
AAL : 11.33 (+0.44%)
DAL : 47.44 (-2.39%)
ALK : 40.40 (-0.88%)
LUV : 28.61 (+0.49%)
CCL : 18.72 (+0.59%)
Markets Today: Stocks Lower on Concern about Hawkish Global Central Banks

Morning Markets December E-Mini S&P 500 futures (ESZ2 3) are down -0.32%, and the Dec Nasdaq 100 E-Mini futures (NQZ2 3) are down -0.33%. Stock index futures this morning are mildly lower, following losses...

ESU24 : 5,534.75 (+0.24%)
NQU24 : 19,972.50 (+0.23%)
FL : 24.92 (-2.35%)
URBN : 41.05 (-3.77%)
NKE : 75.37 (-19.98%)
DXCM : 113.38 (-1.01%)
HPQ : 35.02 (+0.89%)
MORF : 34.07 (+0.18%)
WBD : 7.44 (+1.22%)
PARA : 10.39 (+1.27%)
DIS : 99.29 (-2.82%)
NFLX : 674.88 (-1.38%)
3 Biotech Buyout Targets to Watch

The trio all have late-stage therapies with blockbuster potential.

ETNB : 8.01 (+6.23%)
KRTX : 329.83 (+0.03%)
MORF : 34.07 (+0.18%)
Morphic Announces Corporate Highlights and Financial Results for the Second Quarter 2022

Continued enrollment of EMERALD-1 phase 2a trial of MORF-057 in patients with ulcerative colitis Announced key appointments and advancements in leadership...

MORF : 34.07 (+0.18%)
Morphic to Present at 2022 Jefferies Global Healthcare Conference

WALTHAM, Mass., June 09, 2022 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral...

MORF : 34.07 (+0.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Morphic Holding Inc. is a biopharmaceutical company. It focuses on the discovery and development of oral small-molecule integrin therapeutics for autoimmune, cardiovascular and metabolic diseases, as well as fibrosis and cancer. Morphic Holding Inc. is based in Waltham, Massachusetts.

See More

Key Turning Points

3rd Resistance Point 36.21
2nd Resistance Point 35.46
1st Resistance Point 34.76
Last Price 34.07
1st Support Level 33.31
2nd Support Level 32.56
3rd Support Level 31.86

See More

52-Week High 62.08
Fibonacci 61.8% 45.76
Fibonacci 50% 40.71
Fibonacci 38.2% 35.67
Last Price 34.07
52-Week Low 19.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar